clinical factors and frequency of disease-modifying therapy (DMT) changes/interruptions in relapsing-remitting multiple sclerosis (RRMS) patients have not been well defined. The aim of this study was to describe reasons of MS treatment modifications in a large cohort of Italian MS patients.
Patti, F., Chisari, C.g., D'Amico, E., Annovazzi, P., Banfi, P., Bergamaschi, R., et al. (2020). Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study). MULTIPLE SCLEROSIS AND RELATED DISORDERS, 42, 102124 [10.1016/j.msard.2020.102124].
Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study)
Marfia, Girolama Alessandra;Centonze, Diego
2020-07-01
Abstract
clinical factors and frequency of disease-modifying therapy (DMT) changes/interruptions in relapsing-remitting multiple sclerosis (RRMS) patients have not been well defined. The aim of this study was to describe reasons of MS treatment modifications in a large cohort of Italian MS patients.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
1-s2.0-S2211034820301577-main.pdf
solo utenti autorizzati
Licenza:
Non specificato
Dimensione
2.12 MB
Formato
Adobe PDF
|
2.12 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
